25 results
Thumbnail

D2.380 - Incidental Low Serum IgE: A Marker of Underlying Inborn Errors of Immunity?

Thumbnail

D2.383 - Ocular Cicatricial Pemphigoid: Experience with Methotrexate immunosuppression in a case series from Mar del Plata, Argentina

Thumbnail

D2.389 - Optic disc swelling in Common variable immunodeficiency, two cases from a small U.K. cohort

Thumbnail

D2.381 - Early Infantile Immune Dysregulation with an Atopic Phenotype: A Case of Genetically Confirmed Otulipenia

Thumbnail

D2.382 - Contribution of Clinical and Laboratory Findings to Genetic Testing Decisions and Diagnostic Yield in Patients with Suspected Primary Immunodeficiency

Thumbnail

D2.384 - Early inflammatory manifestations in a child carrying a heterozygous TREX1 variant: possible evolving interferonopathy?

Thumbnail

D2.385 - Granulomatous and Lymphocytic Inerstitial Lung Disease (GLILD) in Common Variable Immunodeficiencies (CVIDs): preliminary results of a multicenter retrospective observational study

Thumbnail

D2.386 - Intravenous Immunoglobulin–Associated Severe Prolonged Neutropenia: A Rare but Life-Threatening Complication in Primary Immunodeficiency

Thumbnail

D2.387 - Hemophagocytic Lymphohistiocytosis and Progressive Neurological Involvement in Two Patients with Severe Congenital Neutropenia Due to VPS45 Deficiency

Thumbnail

D2.388 - Is Sarcoidosis a preliminary feature of Inborn Errors of Immunity?

Thumbnail

D2.390 - Evaluation of CD4⁻ CD8⁻ T Cell Population According to Patient Diagnostic Groups: A Single-Center Study

Thumbnail

D2.391 - Assessment of Small Airway Dysfunction by Impulse Oscillometry in Patients with CVID and Selective IgA Deficiency

Thumbnail

D2.471 - Efficacy of omalizumab in the treatment of chronic spontaneous urticaria in children

Thumbnail

D2.473 - Omalizumab as adjuvant therapy in drug desensitization to chemotherapy- a single Center experience

Thumbnail

D2.475 - Treatment delay and likelihood of remission on omalizumab in chronic spontaneous urticaria: a real-world observational study

Thumbnail

D2.464 - Stapokibart (anti–IL-4Rα monoclonal antibody) across type 2 inflammatory diseases in routine practice: a three-case series of severe atopic dermatitis, chronic urticaria with rhinosinusitis, and immune-related bullous pemphigoid

Thumbnail

D2.465 - Omalizumab Enhances Safety and Supports Completion of Oral Immunotherapy in High-Risk Patients

Thumbnail

D2.466 - More options for the treatment of Chronic Spontaneous Urticaria: Tezepelumab

Thumbnail

D2.467 - Management of Netherton syndrome and hereditary angioedema with concurrent biologic therapy: a novel case

Thumbnail

D2.468 - Real-world effectiveness and safety of dupilumab in pediatric atopic dermatitis: a retrospective cohort study